Health and Fitness Health and Fitness
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012
Tue, June 26, 2012
Mon, June 25, 2012

Cadence Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference In New York City On July 12, 2012


//health-fitness.news-articles.net/content/2012/ .. conference-in-new-york-city-on-july-12-2012.html
Published in Health and Fitness on Thursday, July 5th 2012 at 13:12 GMT by Market Wire   Print publication without navigation


Cadence Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference... -- SAN DIEGO, July 5, 2012 /PRNewswire/ --

Cadence Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference In New York City On July 12, 2012

[ ]

SAN DIEGO, July 5, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's Chief Commercial Officer, Scott Byrd, will present the company's corporate overview on Thursday, July 12, 2012 at 3:30pm Eastern Time (12:30pm Pacific Time) during the 7th Annual JMP Securities Healthcare Conference at the Peninsula New York Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investors section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc. Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of [ www.cadencepharm.com ] under "Events and Presentations." 

Contacts:

William R. LaRue

SVP, CFO                                     

Cadence Pharmaceuticals, Inc.

858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.cadencepharm.com ]


Publication Contributing Sources